The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COM | 901384107 | 19,327,911 | 2,062,744 | SH | SOLE | 2,062,744 | 0 | 0 | |||
Aadi Bioscience, Inc. | COM | 00032Q104 | 12,700,776 | 989,928 | SH | SOLE | 989,928 | 0 | 0 | |||
AbCellera Biologics Inc. | COM | 00288U106 | 105,860,323 | 10,450,180 | SH | SOLE | 10,450,180 | 0 | 0 | |||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 667,421,897 | 41,923,486 | SH | SOLE | 41,923,486 | 0 | 0 | |||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 2,332,229 | 2,591,366 | SH | SOLE | 2,591,366 | 0 | 0 | |||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 14,353,080 | 9,830,877 | SH | SOLE | 9,830,877 | 0 | 0 | |||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 1,534,207 | 3,410,106 | SH | SOLE | 3,410,106 | 0 | 0 | |||
Aerovate Therapeutics, Inc. | COM | 008064107 | 57,922,232 | 1,976,868 | SH | SOLE | 1,976,868 | 0 | 0 | |||
Affimed N.V. | COM | N01045108 | 8,180,069 | 6,596,830 | SH | SOLE | 6,596,830 | 0 | 0 | |||
Akero Therapeutics, Inc. | COM | 00973Y108 | 129,787,114 | 2,368,378 | SH | SOLE | 2,368,378 | 0 | 0 | |||
Alector, Inc. | COM | 014442107 | 6,294,777 | 681,991 | SH | SOLE | 681,991 | 0 | 0 | |||
Aligos Therapeutics, Inc. | COM | 01626L105 | 1,978,602 | 2,076,400 | SH | SOLE | 2,076,400 | 0 | 0 | |||
Altimmune, Inc. | COM | 02155H200 | 10,751,095 | 653,562 | SH | SOLE | 653,562 | 0 | 0 | |||
AnaptysBio, Inc. | COM | 032724106 | 24,045,885 | 775,924 | SH | SOLE | 775,924 | 0 | 0 | |||
Aravive, Inc. | COM | 03890D108 | 4,304,816 | 3,261,224 | SH | SOLE | 3,261,224 | 0 | 0 | |||
argenx SE | SPONSORED ADR | 04016X101 | 106,132,634 | 280,159 | SH | SOLE | 280,159 | 0 | 0 | |||
ARS Pharmaceuticals, Inc. | COM | 82835W108 | 17,115,027 | 2,006,451 | SH | SOLE | 2,006,451 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 605,136,441 | 4,954,855 | SH | SOLE | 4,954,855 | 0 | 0 | |||
Atara Biotherapeutics, Inc. | COM | 046513107 | 2,440,930 | 744,186 | SH | SOLE | 744,186 | 0 | 0 | |||
Athira Pharma, Inc. | COM | 04746L104 | 5,959,080 | 1,879,836 | SH | SOLE | 1,879,836 | 0 | 0 | |||
Atreca, Inc. | CL A COM | 04965G109 | 2,828,328 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | |||
aTyr Pharma, Inc. | COM | 002120202 | 18,757 | 8,565 | SH | SOLE | 8,565 | 0 | 0 | |||
Avidity Biosciences, Inc. | COM | 05370A108 | 9,647,813 | 434,782 | SH | SOLE | 434,782 | 0 | 0 | |||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 2,566,457,206 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | |||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 179,369 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | |||
Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 24,976,894 | 843,814 | SH | SOLE | 843,814 | 0 | 0 | |||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 145,920,191 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | |||
Biohaven Ltd. | COM | G1110E107 | 6,609,517 | 476,190 | SH | SOLE | 476,190 | 0 | 0 | |||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 788,644,924 | 7,620,494 | SH | SOLE | 7,620,494 | 0 | 0 | |||
Biomea Fusion, Inc. | COM | 09077A106 | 17,741,432 | 2,104,559 | SH | SOLE | 2,104,559 | 0 | 0 | |||
bluebird bio, Inc. | COM | 09609G100 | 17,298,028 | 2,499,715 | SH | SOLE | 2,499,715 | 0 | 0 | |||
Cabaletta Bio, Inc. | COM | 12674W109 | 12,432,000 | 1,344,000 | SH | SOLE | 1,344,000 | 0 | 0 | |||
Century Therapeutics, Inc. | COM | 15673T100 | 5,896,114 | 1,149,340 | SH | SOLE | 1,149,340 | 0 | 0 | |||
Cerus Corporation | COM | 157085101 | 58,646,587 | 16,067,558 | SH | SOLE | 16,067,558 | 0 | 0 | |||
Chinook Therapeutics, Inc. | COM | 16961L106 | 66,393,472 | 2,534,102 | SH | SOLE | 2,534,102 | 0 | 0 | |||
CinCor Pharma, Inc. | COM | 17240Y109 | 9,920,635 | 807,212 | SH | SOLE | 807,212 | 0 | 0 | |||
Compass Therapeutics, Inc. | COM | 20454B104 | 7,834,879 | 1,557,630 | SH | SOLE | 1,557,630 | 0 | 0 | |||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 13,608,809 | 2,170,464 | SH | SOLE | 2,170,464 | 0 | 0 | |||
Cyteir Therapeutics, Inc. | COM | 23284P103 | 4,111,995 | 2,492,118 | SH | SOLE | 2,492,118 | 0 | 0 | |||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 22,359,824 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | |||
Denali Therapeutics Inc. | COM | 24823R105 | 30,277,804 | 1,088,738 | SH | SOLE | 1,088,738 | 0 | 0 | |||
Design Therapeutics, Inc. | COM | 25056L103 | 7,101,264 | 692,131 | SH | SOLE | 692,131 | 0 | 0 | |||
DICE Therapeutics, Inc. | COM | 23345J104 | 26,900,858 | 862,207 | SH | SOLE | 862,207 | 0 | 0 | |||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 4,470,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
Entrada Therapeutics, Inc. | COM | 29384C108 | 65,785,873 | 4,865,819 | SH | SOLE | 4,865,819 | 0 | 0 | |||
Fate Therapeutics, Inc. | COM | 31189P102 | 2,176,363 | 215,695 | SH | SOLE | 215,695 | 0 | 0 | |||
FibroGen, Inc. | COM | 31572Q808 | 22,030,880 | 1,375,211 | SH | SOLE | 1,375,211 | 0 | 0 | |||
Foghorn Therapeutics Inc. | COM | 344174107 | 287,272 | 45,027 | SH | SOLE | 45,027 | 0 | 0 | |||
Genetron Holdings Limited | ADS | 37186H100 | 509,943 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | |||
Heron Therapeutics, Inc. | COM | 427746102 | 20,329,195 | 8,131,678 | SH | SOLE | 8,131,678 | 0 | 0 | |||
HOOKIPA Pharma Inc. | COM | 43906K100 | 2,815,183 | 3,475,535 | SH | SOLE | 3,475,535 | 0 | 0 | |||
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 110,354,933 | 969,727 | SH | SOLE | 969,727 | 0 | 0 | |||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 30,314,010 | 1,668,355 | SH | SOLE | 1,668,355 | 0 | 0 | |||
IGM Biosciences, Inc. | COM | 449585108 | 53,685,295 | 3,156,102 | SH | SOLE | 3,156,102 | 0 | 0 | |||
Immatics N.V. | SHS | N44445109 | 45,179,476 | 5,187,081 | SH | SOLE | 5,187,081 | 0 | 0 | |||
Immunocore Holdings plc | ADS | 45258D105 | 143,858,118 | 2,520,731 | SH | SOLE | 2,520,731 | 0 | 0 | |||
Incyte Corporation | COM | 45337C102 | 2,903,967,271 | 36,154,971 | SH | SOLE | 36,154,971 | 0 | 0 | |||
Insmed Incorporated | COM PAR $.01 | 457669307 | 398,601 | 19,950 | SH | SOLE | 19,950 | 0 | 0 | |||
Instil Bio, Inc. | COM | 45783C101 | 3,322,487 | 5,273,789 | SH | SOLE | 5,273,789 | 0 | 0 | |||
Invitae Corporation | COM | 46185L103 | 15,627,785 | 8,402,035 | SH | SOLE | 8,402,035 | 0 | 0 | |||
iTeos Therapeutics, Inc. | COM | 46565G104 | 2,936,257 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | |||
Kala Pharmaceuticals, Inc. | COM | 483119202 | 2,930,416 | 76,813 | SH | SOLE | 76,813 | 0 | 0 | |||
Kezar Life Sciences, Inc. | COM | 49372L100 | 436,100 | 61,946 | SH | SOLE | 61,946 | 0 | 0 | |||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 41,937,663 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | |||
Kodiak Sciences Inc. | COM | 50015M109 | 123,943,108 | 17,310,490 | SH | SOLE | 17,310,490 | 0 | 0 | |||
Kronos Bio, Inc. | COM | 50107A104 | 1,941,005 | 1,198,151 | SH | SOLE | 1,198,151 | 0 | 0 | |||
Krystal Biotech, Inc. | COM | 501147102 | 23,981,162 | 302,716 | SH | SOLE | 302,716 | 0 | 0 | |||
Kymera Therapeutics, Inc. | COM | 501575104 | 71,880,432 | 2,879,825 | SH | SOLE | 2,879,825 | 0 | 0 | |||
Leap Therapeutics, Inc. | COM | 52187K101 | 251,867 | 559,705 | SH | SOLE | 559,705 | 0 | 0 | |||
MacroGenics, Inc. | COM | 556099109 | 5,989,205 | 892,579 | SH | SOLE | 892,579 | 0 | 0 | |||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 448,469,048 | 1,545,113 | SH | SOLE | 1,545,113 | 0 | 0 | |||
Mirati Therapeutics, Inc. | COM | 60468T105 | 63,877,313 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | |||
Natera, Inc. | COM | 632307104 | 4,017,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 1,945,266 | 3,821,740 | SH | SOLE | 3,821,740 | 0 | 0 | |||
Nkarta, Inc. | COM | 65487U108 | 2,396,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
Nurix Therapeutics, Inc. | COM | 67080M103 | 42,625,733 | 3,882,125 | SH | SOLE | 3,882,125 | 0 | 0 | |||
Opthea Limited | SPONSORED ADS | 68386J208 | 14,425,856 | 2,691,391 | SH | SOLE | 2,691,391 | 0 | 0 | |||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 9,225,257 | 1,127,782 | SH | SOLE | 1,127,782 | 0 | 0 | |||
PMV Pharmaceuticals, Inc. | COM | 69353Y103 | 2,801,609 | 322,024 | SH | SOLE | 322,024 | 0 | 0 | |||
POINT Biopharma Global Inc. | COM | 730541109 | 8,522,761 | 1,169,103 | SH | SOLE | 1,169,103 | 0 | 0 | |||
Praxis Precision Medicines, Inc. | COM | 74006W108 | 4,356,150 | 1,830,315 | SH | SOLE | 1,830,315 | 0 | 0 | |||
Prelude Therapeutics Inc. | COM | 74065P101 | 61,147,897 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | |||
Prime Medicine, Inc. | COM | 74168J101 | 19,108,898 | 1,028,466 | SH | SOLE | 1,028,466 | 0 | 0 | |||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 535,118 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | |||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 8,508,848 | 223,976 | SH | SOLE | 223,976 | 0 | 0 | |||
Replimune Group, Inc. | COM | 76029N106 | 124,529,216 | 4,578,280 | SH | SOLE | 4,578,280 | 0 | 0 | |||
Revolution Medicines, Inc. | COM | 76155X100 | 5,293,328 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | |||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 185,046,185 | 6,354,608 | SH | SOLE | 6,354,608 | 0 | 0 | |||
Roivant Sciences Ltd. | SHS | G76279101 | 5,726,057 | 716,653 | SH | SOLE | 716,653 | 0 | 0 | |||
Seagen Inc. | COM | 81181C104 | 6,028,695,304 | 46,912,266 | SH | SOLE | 46,912,266 | 0 | 0 | |||
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 253,968 | 201,562 | SH | SOLE | 201,562 | 0 | 0 | |||
SpringWorks Therapeutics, Inc. | COM | 85205L107 | 39,757,273 | 1,528,538 | SH | SOLE | 1,528,538 | 0 | 0 | |||
Stoke Therapeutics, Inc. | COM | 86150R107 | 10,235,267 | 1,108,913 | SH | SOLE | 1,108,913 | 0 | 0 | |||
Summit Therapeutics Inc. | COM | 86627T108 | 8,500,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 45,917 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | |||
Talis Biomedical Corporation | COM | 87424L108 | 3,398,389 | 7,624,835 | SH | SOLE | 7,624,835 | 0 | 0 | |||
Tango Therapeutics, Inc. | COM | 87583X109 | 5,437,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
TCR2 Therapeutics Inc. | COM | 87808K106 | 752,160 | 753,064 | SH | SOLE | 753,064 | 0 | 0 | |||
Travere Therapeutics, Inc. | COM | 89422G107 | 25,767,113 | 1,225,255 | SH | SOLE | 1,225,255 | 0 | 0 | |||
TScan Therapeutics, Inc. | COM | 89854M101 | 4,316,428 | 2,784,792 | SH | SOLE | 2,784,792 | 0 | 0 | |||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 21,820,225 | 470,974 | SH | SOLE | 470,974 | 0 | 0 | |||
Vaxcyte, Inc. | COM | 92243G108 | 2,344,036 | 48,885 | SH | SOLE | 48,885 | 0 | 0 | |||
Vera Therapeutics, Inc. | CL A | 92337R101 | 6,449,994 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | |||
Verastem, Inc. | COM | 92337C104 | 10,863,032 | 26,988,898 | SH | SOLE | 26,988,898 | 0 | 0 | |||
Veru Inc. | COM | 92536C103 | 8,498,577 | 1,609,579 | SH | SOLE | 1,609,579 | 0 | 0 | |||
Verve Therapeutics, Inc. | COM | 92539P101 | 27,409,856 | 1,416,530 | SH | SOLE | 1,416,530 | 0 | 0 | |||
Vincerx Pharma, Inc. | COM | 92731L106 | 246,207 | 241,379 | SH | SOLE | 241,379 | 0 | 0 | |||
Vor Biopharma Inc. | COM | 929033108 | 9,748,401 | 1,465,925 | SH | SOLE | 1,465,925 | 0 | 0 | |||
Xencor, Inc. | COM | 98401F105 | 3,206,227 | 123,127 | SH | SOLE | 123,127 | 0 | 0 | |||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 29,637,126 | 751,639 | SH | SOLE | 751,639 | 0 | 0 | |||
Zymeworks Inc. | COM | 98985Y108 | 13,428,590 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | |||
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 19,229,604 | 23,500,000 | PRN | SOLE | 23,500,000 | 0 | 0 | |||
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 8,058,143 | 10,300,000 | PRN | SOLE | 10,300,000 | 0 | 0 |